Capital International, Inc. Dexcom Inc Transaction History

Capital International, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $25,530 - $29,732	227 Added 2.22%	10,465 $1.34 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $21,320 - $25,198	205 Added 2.04%	10,238 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $55,661 - $80,348	-655 Reduced 6.13%	10,033 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $425,956 - $525,430	-5,579 Reduced 34.3%	10,688 $861,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $861,093 - $1.68 Million	12,665 Added 351.61%	16,267 $1.21 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $193,428 - $267,691	2,056 Added 132.99%	3,602 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $200,779 - $251,719	1,546 New	1,546 $830,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.